EUFAMI attends EU-level working meeting on transition care

Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe) and the European Brain Council (EBC) organised a working meeting in Brussels on Tuesday 11th July 2017 to discuss the issue of transition of care in mental health services.  It was attended by EUFAMI board member  Spyros Zorbas.

The working meeting, moderated by International Health Policy Advisor and former MEP John Bowis, assembled key stakeholders with an interest in improving the mental health outcomes of patients in Europe, with a focus on the transition of care from childhood to adulthood in mental health services – taking ADHD as an example.

Several initiatives at EU and country level have started to focus on issues of transition, but there remains a pressing need to ensure patients about to enter the transition phase are adequately supported.

The European Psychiatric Association President Silvana Galderisi, ADHD Europe President Andrea Bilbow OBE, as well as neurologists, patient representatives, academics and mental health advocacy groups explored the reasons why transition care is currently suboptimal and agreed on a roadmap for driving improvements in this area.

The perspective of family carers was underlined by several participants. EUFAMI board member Spyros Zorbas reiterated the importance of family support in ADHD.   Mr. Zorbas has been running a series of support groups for adults with ADHD in Greece since 2008.

Movement to transform mental health g...

A profound shift in the way mental health care is delivered globally is underway, according to Michelle Funk and Natalie Drew at the World Health Organization's Department of Mental Health and Subs...

Read

EUFAMI joins EU forensic mental healt...

EUFAMI is delighted to be joining the European Study on Violence Risk and Mental Disorders (EUVIORMED), an EU project working on improving and standardising forensic psychiatric care across Europe....

Read

EUFAMI attends 30th ECNP Congress in ...

EUFAMI attended the  30th  European College of Neuropsychopharmacology Congress in Paris between 2-5 September.  The event brings together some 6000 delegates, including neuroscientists, psychiatri...

Read